Integra To Acquire U.S. Rights To Tornier's Salto Talaris And Salto XT Products

(RTTNews) - Integra LifeSciences Holdings Corp. (IART) and Tornier N.V. (TRNX) announced an agreement under which Integra will acquire the United States rights to Tornier's Salto Talaris and Salto XT ankle replacement products and Tornier's Futura silastic toe replacement products, for an undisclosed cash payment. The agreement also includes an option to purchase, in the future, the rights to the Salto Talaris, Salto XT, Salto Mobile, and Futura silastic toe replacement products outside the U.S.

Integra said revenues in the U.S. from the acquired products were approximately $15.5 million in 2014. During 2015, Integra expects the contribution to adjusted earnings per share to be immaterial.